BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace


BenevolentAI logo

Clinical Trials


AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discoverytowards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, having discovered a leading repurposed drug candidate for COVID-19. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.

Posts Mentioning This Company

9 Publicly Traded Biotechs Utilizing AI-based Research Platforms

In a report, The Landscape of Artificial Intelligence (AI) In The Pharmaceutical Research, the community of AI-driven drug discovery companies is represented by more than 400 players, focusing on a wide scale of applications from target discovery to clinics. A few companies managed to build sophisticated AI-driven end-to-end drug discovery platforms, …

BenevolentAI Pioneers AI-Driven Drug Discovery for ALS Treatment

Incorporating AI in drug discovery is rapidly becoming a common practice in the pharmaceutical industry. The recent undertakings of UK-based biotech company BenevolentAI, which is listed on Euronext Amsterdam (BAI), further validate this trend. The company utilises advanced AI technologies to streamline biopharmaceutical discovery, a fact well illustrated by the …

2022 in Retrospect: 10 Breakthrough Technologies in Drug Discovery

Reflecting on 2022, let’s review several breakthrough technologies that are shaping the future of biology research and drug discovery. I have prepared this list based on a review of recent articles published on BiopharmaTrend -- by myself and by numerous guest authors.

Insilico Medicine and Other AI Drug Discovery Companies Leading the Race

A Hong Kong-based artificial intelligence (AI)-driven drug discovery company Insilico Medicine has just announced the appointment of Dr. Michelle Chen as a Chief Business Officer (CBO) to oversee the company’s corporate strategies and business development activities. Dr. Chen is a lofty hire, having more than 20 years of experience in …

Pharma and Healthcare AI Vendors Join Forces To Accelerate Progress In Drug Discovery

Today Basel is crowded with some of the top business and research leaders representing a young and rapidly growing industry of artificial intelligence (AI) in healthcare and pharmaceutical research. They come together to announce mission and launch activities of a global Alliance for Artificial Intelligence in Healthcare (AAIH), which is …

How AI Helps Validate Life Science Hypotheses

In this interview, Dr. Jackie Hunter, CEO at BenevolentAI, provides insights into how the company’s AI-driven platform helps scientists create and validate complex research hypotheses faster and more efficiently.
SHARE Share in Facebook Share in Twitter Share in LinkedIn Send by email